Eisai is expanding the scope of its cancer drug pipeline through a partnership with Bliss Biopharmaceutical, whose lead program addresses a hot oncology target that makes it a potential competitor to a blockbuster AstraZeneca product.
Under the collaboration agreement announced Monday,…
Source: medcitynews.com – Read more
SYNLAB Italia Cyber-Incident May Have Leaked Personal Data – The Cyber Express
SYNLAB Italia experienced a cyber incident that may have resulted in the leak of personal data. The extent of the breach is unclear, and the